Lupron Depot 22.5mg Inj Kit (3mth)
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection. If you will be self-administering the injection, your doctor or nurse will instruct you on the proper technique.
Administration Techniques
Some products are designed to be injected into the fatty tissue under the skin, while others must be injected into a muscle. If you are unsure about the correct administration method, consult with your doctor or pharmacist.
Precautions and Safety Measures
Before and after handling the medication, wash your hands thoroughly. Wear gloves when mixing and administering the medication to prevent exposure. Rotate the injection site with each dose to minimize the risk of tissue damage.
Inspecting the Medication
Do not use the medication if the solution appears cloudy, is leaking, or contains particles. Additionally, do not use the medication if the solution has changed color. Avoid applying pressure to the injection site, such as wearing a tight waistband or belt.
Disposal of Needles and Supplies
Dispose of used needles and other sharp objects in a designated needle/sharp disposal box. Do not reuse needles or other items. When the disposal box is full, follow local regulations for proper disposal. If you have any questions or concerns, consult with your doctor or pharmacist.
Continuing Treatment
Continue using this medication as directed by your doctor or healthcare provider, even if you are feeling well.
Storage and Disposal
In most cases, this medication will be administered in a hospital or doctor's office. If you need to store the medication at home, follow the storage instructions provided by your doctor.
Missed Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Maintain a healthy diet and regular exercise to help manage potential side effects like weight gain, bone loss, and cardiovascular risks.
- Discuss bone health with your doctor, including calcium and vitamin D supplementation, and potential need for bone-strengthening medications.
- Monitor blood sugar and cholesterol levels regularly as advised by your doctor.
- Report any new or worsening symptoms, especially chest pain, shortness of breath, or changes in urination.
Available Forms & Alternatives
Available Strengths:
- Lupron Depot 3.75mg Inj/1mth Kit
- Lupron Depot 7.5mg Inj/1mth Kit
- Lupron Depot 22.5mg Inj Kit (3mth)
- Lupron Depot-Ped 15mg Inj/1 Mth Kit
- Lupron Depot 30mg Inj/4 Mth Kit
- Lupron Depot 11.25mg Inj/3 Mth Kit
- Lupron Depot-Ped 11.25mginj/1 Mth
- Lupron Depot-Ped 7.5mg Inj/1mth Kit
- Lupron Depot 45mg Inj/6 Mth Kit
- Lupron Depot-Ped 11.25mginj/3 Mth
- Lupron Depot-Ped 30mg Inj/3 Mth Kit
- Lupron Depot-Ped 45mg Inj 6/mth Kit
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Signs of high blood sugar: confusion, drowsiness, increased thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath.
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased sputum production or change in sputum color, painful urination, mouth sores, or a wound that won't heal.
Signs of high blood pressure: severe headache or dizziness, fainting, or changes in vision.
Signs of dehydration: dry skin, mouth, or eyes, thirst, rapid heartbeat, dizziness, rapid breathing, or confusion.
Signs of liver problems: dark urine, fatigue, decreased appetite, upset stomach or stomach pain, light-colored stools, vomiting, or yellow skin or eyes.
New or worsening bone pain.
Difficulty urinating or changes in urine output.
Severe back pain.
Seizures.
Blood in the urine.
Abnormal sensations such as burning, numbness, or tingling.
Severe dizziness or fainting.
Irregular heartbeat (fast, slow, or abnormal).
Shortness of breath, significant weight gain, or swelling in the arms or legs.
Inability to move.
Behavioral and mood changes, particularly in children, including aggression, crying, depression, mood swings, restlessness, and irritability. If you notice any new or worsening behavioral or mood changes, contact your doctor immediately.
A rare but serious pituitary gland problem (pituitary apoplexy) can occur, usually within 2 weeks of the first dose. Seek medical help right away if you experience a sudden headache, vomiting, fainting, mood changes, eye weakness, inability to move your eyes, or changes in vision.
Severe skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions, can occur. These reactions can be life-threatening and may affect other organs. Seek medical help immediately if you notice signs such as red, swollen, blistered, or peeling skin; red or irritated eyes; sores in your mouth, throat, nose, eyes, genitals, or skin; fever; chills; body aches; shortness of breath; or swollen glands.
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:
Headache.
Dizziness, fatigue, or weakness.
Decreased appetite.
Constipation.
Upset stomach or vomiting.
Difficulty sleeping.
Irritation at the injection site.
Back, muscle, or joint pain.
Flu-like symptoms.
* Common cold symptoms.
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Worsening bone pain or urinary symptoms (especially in the first few weeks of treatment, indicating a 'tumor flare')
- Sudden chest pain, shortness of breath, or weakness on one side of the body (signs of cardiovascular events)
- Increased thirst, frequent urination, or unexplained weight loss (signs of high blood sugar/diabetes)
- Severe headache, confusion, or seizures (rare, but possible)
- Severe injection site reactions (e.g., abscess, ulceration)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Your gender, as this medication is not approved for use in females. If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the potential risks with your doctor, as this medication may harm an unborn baby.
Any other medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins. This is crucial because this medication may interact with other drugs or exacerbate existing health problems.
All your health problems, as they may affect the safety and efficacy of this medication.
To ensure your safety, always consult with your doctor before starting, stopping, or changing the dose of any medication. Verify that it is safe to take this medication with all your other medications and health conditions. Your doctor and pharmacist will work together to determine the best course of treatment for you.
Precautions & Cautions
Regular blood tests and bone density checks are crucial while taking this medication, as directed by your doctor. Additionally, inform all your healthcare providers and laboratory personnel that you are taking this drug, as it may affect the results of certain lab tests.
There is a risk of developing high blood sugar, including new-onset or worsening diabetes, associated with this medication. Monitor your blood sugar levels as advised by your doctor. If you smoke, consult your doctor, as this medication may also increase cholesterol levels.
Long-term use of this drug may lead to weakened bones, increasing the risk of fractures. If you experience bone pain, contact your doctor immediately. Certain products containing this medication are not approved for use in individuals aged 65 or older or in children, so discuss any concerns with your doctor.
People with bladder blockage or spinal cord compression may be at a higher risk of severe and potentially life-threatening complications. Furthermore, reducing male hormones in the body may increase the risk of abnormal heart rhythms, known as prolonged QT interval. Discuss any concerns with your doctor.
During the initial few weeks of treatment, you may experience a worsening of symptoms, known as a tumor flare reaction. In rare cases, this can lead to paralysis or even death, particularly in individuals with advanced prostate cancer. If you have urinary blockage or cancer in the spine, inform your doctor, and seek immediate medical attention if you experience difficulty urinating or moving your legs. Report any persistent or bothersome side effects, such as bone pain, numbness, tingling, blood in the urine, or urinary difficulties, to your doctor.
Males taking this medication may have a slightly increased risk of heart attack, stroke, or sudden cardiac death. Although this risk is low, seek immediate medical help if you experience chest pain, weakness on one side of the body, speech or cognitive difficulties, balance problems, facial drooping, or vision changes.
This medication may also affect fertility, so discuss any concerns with your doctor if you are planning to father a child.
Overdose Information
Overdose Symptoms:
- No clinical experience with overdose in humans. Animal studies showed dyspnea, decreased activity, and injection site irritation at high doses.
What to Do:
There is no specific antidote. Management should be symptomatic and supportive. Call 1-800-222-1222 (Poison Control) or seek immediate medical attention.
Drug Interactions
Moderate Interactions
- Drugs that prolong QT interval (e.g., Class IA antiarrhythmics, Class III antiarrhythmics, some antipsychotics, macrolide antibiotics, fluoroquinolones): Potential for additive QT prolongation. Use with caution.
- Androgen receptor pathway inhibitors (e.g., enzalutamide, abiraterone): While often used sequentially or in combination in advanced prostate cancer, careful monitoring for additive adverse effects (e.g., cardiovascular, metabolic) is warranted.
Monitoring
Baseline Monitoring
Rationale: To establish baseline and confirm suppression to castrate levels.
Timing: Prior to initiation of therapy
Rationale: To establish baseline and monitor response to therapy for prostate cancer.
Timing: Prior to initiation of therapy
Rationale: GnRH agonists can cause bone loss; baseline assessment is important, especially for patients at risk of osteoporosis.
Timing: Prior to initiation of therapy
Rationale: GnRH agonists are associated with increased risk of cardiovascular events and diabetes.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Every 3 months (prior to next dose)
Target: â¤50 ng/dL (castrate level)
Action Threshold: >50 ng/dL (investigate non-response or non-compliance)
Frequency: Every 3-6 months or as clinically indicated
Target: Declining or stable at low levels
Action Threshold: Rising PSA (suggests disease progression)
Frequency: Periodically (e.g., every 6-12 months)
Target: Normal ranges
Action Threshold: Elevated levels (consider diabetes management)
Frequency: Periodically (e.g., every 6-12 months)
Target: Normal ranges
Action Threshold: Dyslipidemia (consider lipid management)
Frequency: Every 1-2 years for long-term therapy
Target: Maintain optimal BMD
Action Threshold: Significant bone loss (consider bone-sparing agents)
Symptom Monitoring
- Hot flashes
- Fatigue
- Decreased libido
- Erectile dysfunction
- Injection site reactions (pain, swelling, redness)
- Bone pain (especially during initial 'flare')
- Urinary symptoms (worsening during 'flare')
- Signs of cardiovascular events (chest pain, shortness of breath, leg swelling)
- Symptoms of diabetes (increased thirst, urination, unexplained weight loss)
- Mood changes, depression
Special Patient Groups
Pregnancy
Contraindicated in pregnant women. Leuprolide can cause fetal harm when administered to a pregnant woman. It is a GnRH agonist and can cause abortion, fetal harm, or birth defects.
Trimester-Specific Risks:
Lactation
Not applicable. Leuprolide is not indicated for use in women, and specifically not in lactating women. It is unknown if leuprolide is excreted in human milk.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established for the treatment of advanced prostate cancer. Lupron Depot is approved for central precocious puberty in pediatric patients, but the 22.5mg 3-month formulation is not typically used for this indication.
Geriatric Use
No overall differences in safety or effectiveness were observed between older and younger patients. However, the greater sensitivity of some older individuals cannot be ruled out. Given that prostate cancer primarily affects older men, the majority of patients treated with leuprolide are geriatric.
Clinical Information
Clinical Pearls
- Patients should be warned about the initial 'tumor flare' (transient worsening of symptoms like bone pain, urinary obstruction) during the first few weeks of treatment due to the initial surge in testosterone. Anti-androgens (e.g., bicalutamide) are often co-administered for the first few weeks to mitigate this effect.
- Long-term use of GnRH agonists is associated with decreased bone mineral density, increasing the risk of osteoporosis and fractures. Consider baseline and periodic bone density scans and discuss bone health strategies.
- Monitor for metabolic changes, including hyperglycemia and dyslipidemia, as GnRH agonists can increase the risk of diabetes and cardiovascular events.
- Ensure proper injection technique (subcutaneous or intramuscular) as per manufacturer instructions to ensure sustained release and efficacy.
- Patients should be advised that sexual function and libido will likely be significantly reduced due to testosterone suppression.
Alternative Therapies
- Other GnRH agonists (e.g., goserelin, triptorelin, histrelin)
- GnRH antagonists (e.g., degarelix, relugolix)
- Androgen receptor pathway inhibitors (e.g., enzalutamide, apalutamide, darolutamide)
- Androgen synthesis inhibitors (e.g., abiraterone acetate)
- Bilateral orchiectomy (surgical castration)
- Chemotherapy (e.g., docetaxel, cabazitaxel)
- Radium-223 dichloride (for symptomatic bone metastases)